

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antimicrobial humoral response (GO:0019730) | 9.44133032 |
| 2 | mucosal immune response (GO:0002385) | 8.96957260 |
| 3 | organ or tissue specific immune response (GO:0002251) | 8.46618258 |
| 4 | response to peptidoglycan (GO:0032494) | 8.42291732 |
| 5 | response to fungus (GO:0009620) | 7.40746293 |
| 6 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 7.10445698 |
| 7 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 7.10445698 |
| 8 | detection of other organism (GO:0098543) | 6.81387184 |
| 9 | detection of bacterium (GO:0016045) | 6.77604044 |
| 10 | oxygen transport (GO:0015671) | 6.36400912 |
| 11 | cellular extravasation (GO:0045123) | 5.80384506 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 5.69453526 |
| 13 | intracellular estrogen receptor signaling pathway (GO:0030520) | 5.61655972 |
| 14 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.50941913 |
| 15 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.46882145 |
| 16 | cell killing (GO:0001906) | 5.40341378 |
| 17 | neutrophil activation (GO:0042119) | 5.30387757 |
| 18 | gas transport (GO:0015669) | 5.28318796 |
| 19 | defense response to Gram-positive bacterium (GO:0050830) | 5.23214636 |
| 20 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.13552334 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.02838018 |
| 22 | response to host immune response (GO:0052572) | 5.02838018 |
| 23 | negative regulation of growth of symbiont in host (GO:0044130) | 4.91799887 |
| 24 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.91799887 |
| 25 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.91799887 |
| 26 | regulation of growth of symbiont in host (GO:0044126) | 4.91799887 |
| 27 | granulocyte activation (GO:0036230) | 4.79703540 |
| 28 | detection of external biotic stimulus (GO:0098581) | 4.77381053 |
| 29 | leukocyte aggregation (GO:0070486) | 4.64725451 |
| 30 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.63504563 |
| 31 | response to host (GO:0075136) | 4.57028869 |
| 32 | response to host defenses (GO:0052200) | 4.57028869 |
| 33 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.57028869 |
| 34 | detection of biotic stimulus (GO:0009595) | 4.35683139 |
| 35 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.34919671 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.29089518 |
| 37 | negative regulation of interleukin-8 production (GO:0032717) | 4.26145141 |
| 38 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 4.17002631 |
| 39 | hemoglobin metabolic process (GO:0020027) | 4.14251425 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.07944093 |
| 41 | superoxide anion generation (GO:0042554) | 4.04333456 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.73543343 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 3.73543343 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.73543343 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.73543343 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.73543343 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.73543343 |
| 48 | defense response to bacterium (GO:0042742) | 3.67572421 |
| 49 | respiratory burst (GO:0045730) | 3.62181930 |
| 50 | phagosome maturation (GO:0090382) | 3.54237946 |
| 51 | regulation of natural killer cell differentiation (GO:0032823) | 3.53404249 |
| 52 | negative regulation of cell killing (GO:0031342) | 3.51192652 |
| 53 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.51192652 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.46241653 |
| 55 | negative regulation of interleukin-6 production (GO:0032715) | 3.46015674 |
| 56 | modification of morphology or physiology of other organism (GO:0035821) | 3.40764825 |
| 57 | cellular response to interleukin-6 (GO:0071354) | 3.39417266 |
| 58 | neutrophil mediated immunity (GO:0002446) | 3.34724308 |
| 59 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.34651247 |
| 60 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.30740054 |
| 61 | response to bacterium (GO:0009617) | 3.28506628 |
| 62 | leukocyte degranulation (GO:0043299) | 3.28176691 |
| 63 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.28101139 |
| 64 | regulation of mast cell degranulation (GO:0043304) | 3.25010130 |
| 65 | myeloid cell development (GO:0061515) | 3.10931005 |
| 66 | macrophage activation involved in immune response (GO:0002281) | 3.10637463 |
| 67 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.09450782 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 3.08931759 |
| 69 | activated T cell proliferation (GO:0050798) | 3.06668492 |
| 70 | regulation of gamma-delta T cell activation (GO:0046643) | 3.05677462 |
| 71 | negative regulation of interleukin-12 production (GO:0032695) | 3.04286500 |
| 72 | myeloid cell activation involved in immune response (GO:0002275) | 3.03077128 |
| 73 | mast cell activation (GO:0045576) | 3.03043245 |
| 74 | citrulline biosynthetic process (GO:0019240) | 2.99640355 |
| 75 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.98029079 |
| 76 | neutrophil chemotaxis (GO:0030593) | 2.97054782 |
| 77 | regulation of mast cell activation (GO:0033003) | 2.96411896 |
| 78 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95420128 |
| 79 | positive regulation of osteoblast proliferation (GO:0033690) | 2.94941617 |
| 80 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.93883891 |
| 81 | erythrocyte maturation (GO:0043249) | 2.93574518 |
| 82 | detection of molecule of bacterial origin (GO:0032490) | 2.93216327 |
| 83 | regulation of leukocyte degranulation (GO:0043300) | 2.91071355 |
| 84 | neutrophil migration (GO:1990266) | 2.89597013 |
| 85 | response to muramyl dipeptide (GO:0032495) | 2.89551472 |
| 86 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.87967920 |
| 87 | erythrocyte development (GO:0048821) | 2.86881611 |
| 88 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.85944198 |
| 89 | megakaryocyte development (GO:0035855) | 2.85453807 |
| 90 | microglial cell activation (GO:0001774) | 2.84302984 |
| 91 | positive regulation of granulocyte differentiation (GO:0030854) | 2.83625003 |
| 92 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.83512010 |
| 93 | response to methylmercury (GO:0051597) | 2.78348398 |
| 94 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.77679331 |
| 95 | heme biosynthetic process (GO:0006783) | 2.77382881 |
| 96 | innate immune response in mucosa (GO:0002227) | 10.6826389 |
| 97 | killing of cells of other organism (GO:0031640) | 10.1912334 |
| 98 | disruption of cells of other organism (GO:0044364) | 10.1912334 |
| 99 | antibacterial humoral response (GO:0019731) | 10.1297994 |
| 100 | defense response to fungus (GO:0050832) | 10.0136145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.68366283 |
| 2 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.04177708 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.80768453 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.75897427 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.46092035 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.42950928 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.25852370 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.25550819 |
| 9 | VDR_24763502_ChIP-Seq_THP-1_Human | 3.21922511 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.19041377 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.00230511 |
| 12 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.97566666 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.96234668 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.90809380 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.82132827 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.80747137 |
| 17 | GATA1_19941826_ChIP-Seq_K562_Human | 2.68985629 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48330233 |
| 19 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.44103960 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.31736731 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.31333316 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.31127694 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.30628674 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.28273420 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.27443254 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.24304154 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.23985848 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21528311 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.14963298 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.13307943 |
| 31 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.11733596 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.10469341 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.09109091 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08523883 |
| 35 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.08419441 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.03944012 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.02446147 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.00724486 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.93996085 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87568668 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85597626 |
| 42 | GATA2_19941826_ChIP-Seq_K562_Human | 1.85447029 |
| 43 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.77715544 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.74908482 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.72969548 |
| 46 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.68998882 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.66637362 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66284343 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64452889 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.63139724 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.62382157 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.62029843 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59691766 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57168165 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52045775 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.51297737 |
| 57 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.51231937 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50541736 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49704095 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49483442 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.49039757 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.45072898 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45061054 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.40943890 |
| 65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38770470 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37315213 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36517695 |
| 68 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.35635327 |
| 69 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.32111076 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32110737 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30526961 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26130960 |
| 73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24487947 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23097396 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20922117 |
| 76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20582893 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19963882 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18518413 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17037034 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12202534 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11552587 |
| 82 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.11383409 |
| 83 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.11371426 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10654475 |
| 85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09166730 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05747705 |
| 87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05301692 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05105748 |
| 89 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02950791 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01796075 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01495946 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01128506 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97108757 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95738680 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93881290 |
| 96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92258806 |
| 97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92103484 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.90237109 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84555159 |
| 100 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.81191236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.16795726 |
| 2 | MP0003436_decreased_susceptibility_to | 4.07920869 |
| 3 | MP0009785_altered_susceptibility_to | 3.94596521 |
| 4 | MP0003656_abnormal_erythrocyte_physiolo | 3.71607739 |
| 5 | MP0003724_increased_susceptibility_to | 3.64951042 |
| 6 | MP0004147_increased_porphyrin_level | 3.33169540 |
| 7 | MP0002419_abnormal_innate_immunity | 3.27679226 |
| 8 | MP0005025_abnormal_response_to | 3.24792369 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.91111245 |
| 10 | MP0009278_abnormal_bone_marrow | 2.63514982 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.50027893 |
| 12 | MP0000685_abnormal_immune_system | 2.42492438 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.37267867 |
| 14 | MP0008260_abnormal_autophagy | 2.35114570 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.30296920 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.28657062 |
| 17 | MP0001819_abnormal_immune_cell | 2.24915401 |
| 18 | MP0001800_abnormal_humoral_immune | 2.21548757 |
| 19 | MP0005387_immune_system_phenotype | 2.16642733 |
| 20 | MP0001790_abnormal_immune_system | 2.16642733 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.10285625 |
| 22 | MP0001545_abnormal_hematopoietic_system | 2.09314803 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 2.09314803 |
| 24 | MP0003828_pulmonary_edema | 2.08079652 |
| 25 | MP0002723_abnormal_immune_serum | 2.07368178 |
| 26 | MP0002398_abnormal_bone_marrow | 2.04554703 |
| 27 | MP0002396_abnormal_hematopoietic_system | 2.00502010 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.99277804 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.96232958 |
| 30 | MP0002405_respiratory_system_inflammati | 1.92684137 |
| 31 | MP0005671_abnormal_response_to | 1.86896634 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.85746436 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.80114992 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.80065442 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.78529181 |
| 36 | MP0005083_abnormal_biliary_tract | 1.76139882 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.74219627 |
| 38 | MP0002722_abnormal_immune_system | 1.73855290 |
| 39 | MP0000716_abnormal_immune_system | 1.73653788 |
| 40 | MP0002132_abnormal_respiratory_system | 1.68948851 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.68902216 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.67774573 |
| 43 | MP0006082_CNS_inflammation | 1.65151386 |
| 44 | MP0003045_fibrosis | 1.59667864 |
| 45 | MP0002429_abnormal_blood_cell | 1.57814642 |
| 46 | MP0001851_eye_inflammation | 1.56354338 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.53070282 |
| 48 | MP0004947_skin_inflammation | 1.47785545 |
| 49 | MP0009764_decreased_sensitivity_to | 1.46704247 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.46026764 |
| 51 | MP0003075_altered_response_to | 1.43782530 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.40761261 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.40155577 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.38665966 |
| 55 | MP0002009_preneoplasia | 1.33668567 |
| 56 | MP0004883_abnormal_blood_vessel | 1.26410107 |
| 57 | MP0008469_abnormal_protein_level | 1.21803209 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.14685383 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.11279641 |
| 60 | MP0001853_heart_inflammation | 1.09113212 |
| 61 | MP0005164_abnormal_response_to | 1.06823081 |
| 62 | MP0000858_altered_metastatic_potential | 1.00873932 |
| 63 | MP0004381_abnormal_hair_follicle | 1.00384071 |
| 64 | MP0003221_abnormal_cardiomyocyte_apopto | 0.96391710 |
| 65 | MP0003866_abnormal_defecation | 0.96327557 |
| 66 | MP0009763_increased_sensitivity_to | 0.95720004 |
| 67 | MP0009765_abnormal_xenobiotic_induced | 0.93541713 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 0.91655211 |
| 69 | MP0000343_altered_response_to | 0.88851165 |
| 70 | MP0002006_tumorigenesis | 0.87422467 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.86365162 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 0.84082816 |
| 73 | MP0001663_abnormal_digestive_system | 0.82566131 |
| 74 | MP0004510_myositis | 0.82090190 |
| 75 | MP0005166_decreased_susceptibility_to | 0.81514133 |
| 76 | MP0000609_abnormal_liver_physiology | 0.78808902 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.75131207 |
| 78 | MP0005390_skeleton_phenotype | 0.75086685 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 0.74309682 |
| 80 | MP0003795_abnormal_bone_structure | 0.72347146 |
| 81 | MP0008004_abnormal_stomach_pH | 0.72046720 |
| 82 | MP0005310_abnormal_salivary_gland | 0.71913487 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 0.70902640 |
| 84 | MP0009931_abnormal_skin_appearance | 0.70855960 |
| 85 | MP0003690_abnormal_glial_cell | 0.68495714 |
| 86 | MP0004130_abnormal_muscle_cell | 0.67866377 |
| 87 | MP0000249_abnormal_blood_vessel | 0.66072854 |
| 88 | MP0003448_altered_tumor_morphology | 0.65848677 |
| 89 | MP0001873_stomach_inflammation | 0.65594917 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.65084175 |
| 91 | MP0000490_abnormal_crypts_of | 0.63294995 |
| 92 | MP0000015_abnormal_ear_pigmentation | 0.62195342 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.61593475 |
| 94 | MP0009115_abnormal_fat_cell | 0.57717684 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.57182372 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.56934816 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.56384374 |
| 98 | MP0005621_abnormal_cell_physiology | 0.56031597 |
| 99 | MP0008057_abnormal_DNA_replication | 0.55977208 |
| 100 | MP0009840_abnormal_foam_cell | 0.52964620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 8.80128805 |
| 2 | Hypochromic anemia (HP:0001931) | 6.62030138 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.92045187 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.43525831 |
| 5 | Microcytic anemia (HP:0001935) | 5.33698541 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.21599021 |
| 7 | Abnormal hemoglobin (HP:0011902) | 5.09468166 |
| 8 | Stomatitis (HP:0010280) | 4.69249878 |
| 9 | Polycythemia (HP:0001901) | 4.65972775 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.63263113 |
| 11 | Poikilocytosis (HP:0004447) | 4.49568786 |
| 12 | Toxemia of pregnancy (HP:0100603) | 4.45514023 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.44277383 |
| 14 | Myositis (HP:0100614) | 4.24105185 |
| 15 | Prolonged bleeding time (HP:0003010) | 4.06649662 |
| 16 | Obstructive lung disease (HP:0006536) | 3.80717036 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.80717036 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.68900974 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.63118501 |
| 20 | Orchitis (HP:0100796) | 3.62156912 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.53636180 |
| 22 | Optic neuritis (HP:0100653) | 3.53636180 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.52069965 |
| 24 | Urticaria (HP:0001025) | 3.43516699 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.42195059 |
| 26 | Recurrent skin infections (HP:0001581) | 3.30838057 |
| 27 | Meningitis (HP:0001287) | 3.30158449 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 3.25794441 |
| 29 | Abnormality of iron homeostasis (HP:0011031) | 3.21207677 |
| 30 | Gingivitis (HP:0000230) | 3.15701744 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.15563963 |
| 32 | Epistaxis (HP:0000421) | 3.08293683 |
| 33 | Petechiae (HP:0000967) | 3.07021475 |
| 34 | Cholelithiasis (HP:0001081) | 3.05986273 |
| 35 | Osteomyelitis (HP:0002754) | 2.97859414 |
| 36 | Abnormal platelet volume (HP:0011876) | 2.88665216 |
| 37 | Keratoconjunctivitis (HP:0001096) | 2.88001368 |
| 38 | Increased IgE level (HP:0003212) | 2.87508581 |
| 39 | Paralysis (HP:0003470) | 2.86603602 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.83509712 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.83509712 |
| 42 | Encephalitis (HP:0002383) | 2.77039764 |
| 43 | Amyloidosis (HP:0011034) | 2.74193252 |
| 44 | Anorexia (HP:0002039) | 2.73291964 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.72004913 |
| 46 | Abnormal gallbladder morphology (HP:0012437) | 2.71311719 |
| 47 | Gingival bleeding (HP:0000225) | 2.71146050 |
| 48 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.69570692 |
| 49 | Cellulitis (HP:0100658) | 2.69032269 |
| 50 | Episodic fever (HP:0001954) | 2.62195663 |
| 51 | Vasculitis (HP:0002633) | 2.59732680 |
| 52 | Granulocytopenia (HP:0001913) | 2.50932430 |
| 53 | Recurrent viral infections (HP:0004429) | 2.40279566 |
| 54 | Leukocytosis (HP:0001974) | 2.33213158 |
| 55 | Hemoptysis (HP:0002105) | 2.32237954 |
| 56 | Increased mean platelet volume (HP:0011877) | 2.32200063 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.29317612 |
| 58 | Hepatosplenomegaly (HP:0001433) | 2.25513693 |
| 59 | Chest pain (HP:0100749) | 2.25452832 |
| 60 | Pustule (HP:0200039) | 2.23222438 |
| 61 | Thrombophlebitis (HP:0004418) | 2.21326393 |
| 62 | Abnormality of T cell physiology (HP:0011840) | 2.19055385 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.16906938 |
| 64 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.15205964 |
| 65 | Reticulocytosis (HP:0001923) | 2.13083181 |
| 66 | Acanthocytosis (HP:0001927) | 2.10608782 |
| 67 | Abnormality of the pericardium (HP:0001697) | 2.09821628 |
| 68 | Increased serum ferritin (HP:0003281) | 2.09758958 |
| 69 | Diaphragmatic weakness (HP:0009113) | 2.09466909 |
| 70 | Autoimmune thrombocytopenia (HP:0001973) | 2.08399001 |
| 71 | Arterial thrombosis (HP:0004420) | 2.07436866 |
| 72 | Panhypogammaglobulinemia (HP:0003139) | 2.07372744 |
| 73 | Abnormality of the fingertips (HP:0001211) | 2.07119233 |
| 74 | Increased cerebral lipofuscin (HP:0011813) | 2.06625872 |
| 75 | Slow saccadic eye movements (HP:0000514) | 2.04206614 |
| 76 | Purpura (HP:0000979) | 2.02159725 |
| 77 | Hypochromic microcytic anemia (HP:0004840) | 11.2828681 |
| 78 | Impaired platelet aggregation (HP:0003540) | 1.98616585 |
| 79 | Abnormal platelet function (HP:0011869) | 1.98616585 |
| 80 | Pallor (HP:0000980) | 1.97519050 |
| 81 | Skin rash (HP:0000988) | 1.95109508 |
| 82 | Abnormality of T cells (HP:0002843) | 1.95057698 |
| 83 | Skin ulcer (HP:0200042) | 1.93707219 |
| 84 | Inflammation of the large intestine (HP:0002037) | 1.93525832 |
| 85 | Menorrhagia (HP:0000132) | 1.90667140 |
| 86 | Abnormality of B cell number (HP:0010975) | 1.89240539 |
| 87 | Sepsis (HP:0100806) | 1.89222532 |
| 88 | Abnormality of the gallbladder (HP:0005264) | 1.89061476 |
| 89 | Abnormality of the pleura (HP:0002103) | 1.88756324 |
| 90 | Cutaneous photosensitivity (HP:0000992) | 1.87912578 |
| 91 | Paresthesia (HP:0003401) | 1.86850059 |
| 92 | Pulmonary embolism (HP:0002204) | 1.86756135 |
| 93 | Eosinophilia (HP:0001880) | 1.85115350 |
| 94 | Gastrointestinal inflammation (HP:0004386) | 1.84063508 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.81074723 |
| 96 | Autoimmune hemolytic anemia (HP:0001890) | 1.80759793 |
| 97 | Splenomegaly (HP:0001744) | 1.79341830 |
| 98 | Increased IgM level (HP:0003496) | 1.78935135 |
| 99 | Hypergammaglobulinemia (HP:0010702) | 1.76450198 |
| 100 | Gangrene (HP:0100758) | 1.74570707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.63233387 |
| 2 | MAP2K3 | 4.33897061 |
| 3 | PRPF4B | 4.01187750 |
| 4 | GRK6 | 3.29424704 |
| 5 | MAP4K1 | 2.86688128 |
| 6 | IRAK4 | 2.53950152 |
| 7 | FES | 2.35235400 |
| 8 | TAOK1 | 2.34083731 |
| 9 | TNK2 | 2.23305388 |
| 10 | BLK | 2.22506854 |
| 11 | MAP3K3 | 2.22400725 |
| 12 | ZAP70 | 2.14669240 |
| 13 | BTK | 2.12651179 |
| 14 | TYK2 | 2.11435651 |
| 15 | SYK | 1.93948841 |
| 16 | ERN1 | 1.87879061 |
| 17 | TAOK2 | 1.85198998 |
| 18 | TEC | 1.83661601 |
| 19 | CSK | 1.77085693 |
| 20 | MAP3K6 | 1.74999385 |
| 21 | MAP3K11 | 1.72742146 |
| 22 | EPHB1 | 1.69354769 |
| 23 | FGR | 1.63148483 |
| 24 | PIK3CG | 1.60273296 |
| 25 | HCK | 1.48979907 |
| 26 | MAP3K14 | 1.44457982 |
| 27 | TXK | 1.41086490 |
| 28 | LYN | 1.35093022 |
| 29 | IRAK1 | 1.31878139 |
| 30 | JAK2 | 1.28917523 |
| 31 | MARK3 | 1.22355920 |
| 32 | KIT | 1.20188549 |
| 33 | ITK | 1.18899585 |
| 34 | MAP3K1 | 1.17958953 |
| 35 | SIK3 | 1.13131878 |
| 36 | IKBKE | 1.10039268 |
| 37 | YES1 | 1.09585548 |
| 38 | JAK3 | 1.01520751 |
| 39 | TESK2 | 0.98411912 |
| 40 | MAP3K5 | 0.96680087 |
| 41 | SMG1 | 0.96451184 |
| 42 | MAPK12 | 0.95765080 |
| 43 | KSR2 | 0.95328009 |
| 44 | EIF2AK1 | 0.94492175 |
| 45 | CLK1 | 0.94343479 |
| 46 | JAK1 | 0.93414376 |
| 47 | PTK2B | 0.93099242 |
| 48 | LCK | 0.92038863 |
| 49 | CSF1R | 0.89921558 |
| 50 | TBK1 | 0.80279272 |
| 51 | CDK19 | 0.79713633 |
| 52 | IRAK2 | 0.79598361 |
| 53 | EPHA3 | 0.79410097 |
| 54 | HIPK2 | 0.78678921 |
| 55 | MAP3K13 | 0.76859149 |
| 56 | PDK1 | 0.73793970 |
| 57 | CDK12 | 0.73768410 |
| 58 | MAP2K4 | 0.72853153 |
| 59 | PDK2 | 0.72288505 |
| 60 | MARK2 | 0.70783238 |
| 61 | BMPR2 | 0.69566000 |
| 62 | PDPK1 | 0.67027525 |
| 63 | MAPK7 | 0.63991698 |
| 64 | IKBKB | 0.63819299 |
| 65 | PIK3CA | 0.60872449 |
| 66 | TRPM7 | 0.60000424 |
| 67 | SIK2 | 0.59991679 |
| 68 | DAPK2 | 0.59068685 |
| 69 | STK10 | 0.57582094 |
| 70 | CDK6 | 0.54058175 |
| 71 | RET | 0.53355020 |
| 72 | FYN | 0.52948891 |
| 73 | PTK6 | 0.52559943 |
| 74 | TRIB3 | 0.49253717 |
| 75 | PIM1 | 0.48956851 |
| 76 | SGK3 | 0.48175124 |
| 77 | MAPK4 | 0.47239076 |
| 78 | WNK1 | 0.46810484 |
| 79 | CAMK1D | 0.46523643 |
| 80 | TAOK3 | 0.46353937 |
| 81 | TGFBR2 | 0.46121108 |
| 82 | MAP2K6 | 0.46082387 |
| 83 | RPS6KL1 | 0.45719155 |
| 84 | RPS6KC1 | 0.45719155 |
| 85 | CAMKK2 | 0.45603151 |
| 86 | LRRK2 | 0.44582663 |
| 87 | STK11 | 0.43303198 |
| 88 | ALK | 0.41061920 |
| 89 | MATK | 0.40602883 |
| 90 | BMX | 0.38467236 |
| 91 | MAP3K2 | 0.37647236 |
| 92 | MAPKAPK2 | 0.37418305 |
| 93 | RPS6KA6 | 0.36414504 |
| 94 | PRKCQ | 0.35032000 |
| 95 | DYRK3 | 0.34584954 |
| 96 | PRKD2 | 0.34398664 |
| 97 | NLK | 0.33156551 |
| 98 | PRKCD | 0.32816706 |
| 99 | KSR1 | 0.32668701 |
| 100 | RAF1 | 0.32567887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.84137586 |
| 2 | Malaria_Homo sapiens_hsa05144 | 3.49198552 |
| 3 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.83287082 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.81465954 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.56065874 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.44958759 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.24561534 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.22897311 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95609958 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.88737263 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.84791800 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82570535 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.81588397 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.76543302 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74849035 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.70080565 |
| 17 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.66001435 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.62987671 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.52384951 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.52021994 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50083521 |
| 22 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.40487753 |
| 23 | Platelet activation_Homo sapiens_hsa04611 | 1.37041073 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.36944683 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35336016 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.32664521 |
| 27 | Hepatitis B_Homo sapiens_hsa05161 | 1.29218139 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28580353 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27173362 |
| 30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25936085 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.23937576 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.23089423 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22292100 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20143158 |
| 35 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.18572990 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.18103453 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15026159 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14000218 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12731312 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.12580254 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08022180 |
| 42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06562672 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06329350 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05431479 |
| 45 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.05338444 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04452080 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.03676373 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03302741 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 1.01396483 |
| 50 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.95751778 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94143468 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 0.93477982 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.92928813 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89854483 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.86701838 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86396032 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85080647 |
| 58 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84295028 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.82370654 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81847571 |
| 61 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78595507 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77812486 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.77811516 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77580308 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.76996382 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76382553 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73601519 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73202360 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73090657 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72286249 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71704253 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69354267 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68811713 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68140685 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64864758 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63294851 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63228534 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63056892 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62154727 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.62094762 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59130410 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58127828 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57659140 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56770302 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.56141673 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56114935 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53325346 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53114046 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52474026 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.51504921 |
| 91 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50625085 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.49996198 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49337739 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.48451995 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47294834 |
| 96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46512326 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45551700 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44353096 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42810858 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42612766 |

